Designed Tripeptides as Potent NPM1 Oligomerization Inhibitors: A Molecular Docking and Dynamics Study Toward New Anticancer Drug Candidates. Int. J. Environ. Sci. Published online January 6, 2026:537-547. doi:10.64252/ckvg7k02